Efficacy versus Effectiveness: A Direct Comparison of the Outcome of Treatment for Mild to Moderate Depression in Randomized Controlled Trials and Daily Practice

被引:50
作者
van der Lem, Rosalind [1 ]
van der Wee, Nic J. A. [1 ,2 ]
van Veen, Tineke [1 ]
Zitman, Frans G. [1 ]
机构
[1] Leiden Univ, Med Ctr Rivierduinen, Dept Psychiat, NL-2300 RC Leiden, Netherlands
[2] Leiden Inst Brain & Cognit, Leiden, Netherlands
关键词
Major depressive disorder; Efficacy; Effectiveness; Randomized controlled trials; Meta-analyses; Treatment outcome; Routine clinical practice; Routine outcome monitoring; SEROTONIN REUPTAKE INHIBITORS; STAR-ASTERISK-D; MAJOR DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; CLINICAL-PRACTICE; MONTGOMERY-ASBERG; REMISSION RATES; DEFINING REMISSION; METAANALYSIS; PSYCHOTHERAPY;
D O I
10.1159/000330890
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Results from randomized controlled trials (RCTs) are considered to give the most reliable information on treatment outcome (efficacy). Yet, the generalizability of efficacy results to daily practice (effectiveness) might be diminished by the design of RCTs. The STAR*D trial approached daily practice as much as possible, but still has some properties of an RCT. In this study, we compare results from treatment of major depressive disorder (MDD) in routine clinical practice to those of RCTs and STAR*D. Methods: Effectiveness in routine clinical practice was compared with efficacy results from 15 meta-analyses on antidepressant, psychotherapeutic and combination treatment and results from STAR*D. Data on daily practice patients and treatments were derived from a routine outcome monitoring (ROM) system. Treatment outcome was defined as proportion of remitters (MADRS <= 10) and within-group effect size. Results: From ROM, 598 patients suffering from a MDD episode according to the MINI-plus were included. Remission percentages were lower in routine practice than in meta-analyses for all treatment modalities (32 vs.40-74%). Differences were less explicit for antidepressants (21 vs. 34-47%) than for individual psychotherapy (27 vs. 34-58%; effect size 0.85 vs. 1.71) and combination therapy (21 vs. 45-63%), since only 60% of the meta-analyses for antidepressants showed significant differences with ROM, while for psychotherapy and combination treatment almost all meta-analyses showed significant differences. No differences in effectiveness were found between routine practice and STAR*D (antidepressants 27 vs. 28%; individual psychotherapy 27 vs. 25%; combination treatment 21 vs. 23%, respectively). Conclusions: Effectiveness of treatment for mild-to-moderate MDD in daily practice is similar to STAR*D and significantly lower than efficacy results from RCTs. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:226 / 234
页数:9
相关论文
共 56 条
  • [41] Steffens D C, 1997, Depress Anxiety, V6, P10, DOI 10.1002/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO
  • [42] 2-9
  • [43] STEWART JW, 1992, AM J PSYCHIAT, V149, P615
  • [44] Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study
    Storosum, JG
    Elferink, AJA
    van Zwieten, BJ
    van den Brink, W
    Gersons, BPR
    van Strik, R
    Broekmans, AW
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (02) : 173 - 179
  • [45] Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials
    Thase, ME
    Haight, BR
    Richard, N
    Rockett, CB
    Mitton, M
    Modell, JG
    VanMeter, S
    Harriett, AE
    Wang, YH
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 974 - 981
  • [46] Thase ME, 1997, ARCH GEN PSYCHIAT, V54, P1009
  • [47] Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
    Thase, ME
    Entsuah, AR
    Rudolph, RL
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 : 234 - 241
  • [48] Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report
    Thase, Michael E.
    Friedman, Edward S.
    Biggs, Melanie M.
    Wisniewski, Stephen R.
    Trivedi, Madhukar H.
    Luther, James F.
    Fava, Maurizio
    Nierenberg, Andrew A.
    McGrath, Patrick J.
    Warden, Diane
    Niederehe, George
    Hollon, Steven D.
    Rush, A. John
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (05) : 739 - 752
  • [49] Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
    Trivedi, MH
    Rush, AJ
    Wisniewski, SR
    Nierenberg, AA
    Warden, D
    Ritz, L
    Norquist, G
    Howland, RH
    Lebowitz, B
    McGrath, PJ
    Shores-Wilson, K
    Biggs, MM
    Balasubramani, GK
    Fava, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (01) : 28 - 40
  • [50] Practical clinical trials - Increasing the value of clinical research for decision making in clinical and health policy
    Tunis, SR
    Stryer, DB
    Clancy, CM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (12): : 1624 - 1632